{"id":35576,"date":"2021-01-11T15:18:57","date_gmt":"2021-01-11T15:18:57","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=35576"},"modified":"2021-03-19T10:54:29","modified_gmt":"2021-03-19T10:54:29","slug":"joel-richard","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/","title":{"rendered":"Jo\u00ebl Richard"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n<h2><b>Jo\u00ebl Richard, PhD, HDR<\/b><b><br>\n<\/b><\/h2>\n<h4>Chief Development Officer at MedinCell<\/h4>\n\t<p>Dr Jo\u00ebl Richard is currently Chief Development Officer at MedinCell (Montpellier, France). He is leading all the drug development activities of the company, based on the proprietary technology BEPO\u00ae for Long-Acting Injectables. (LAIs). These activities comprise formulation and process development, device development, analytical development, process transfer and scale-up, manufacturing and supply of clinical batches, regulatory affairs, non-clinical and clinical development operations, quality and regulatory compliance.<\/p>\n<p>Dr Richard has more than 30 years of experience in chemistry and (bio)pharmaceutical R&amp;D, including several global senior leadership positions in various Biotech and Pharma companies, such as Ipsen (France), Serono (Italy), MerckSerono (Germany), Ethypharm (France). Dr Richard has focused his research activity on new formulation technologies and innovative drug delivery systems (microspheres, nanosystems, self-assembling gels), especially for injectable peptide and protein formulations. He has graduated from Ecole Normale Sup\u00e9rieure (Cachan, France), and got a PhD in Materials Science (Paris VI, France), and the &#8220;Habilitation \u00e0 Diriger les Recherches&#8221; in Chemistry (Bordeaux I, France).<\/p>\n<p>He has published 71 peer-reviewed scientific papers, 8 book chapters and 2 review editorials in various fields. He is the author of 140 international communications and 55 patent families. He has also been serving as an APGI Board Member for 3 years and is a Member of the Controlled Release Society (CRS).<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_gallery.png\" alt=\"Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_gallery\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_gallery\" onerror=\"this.style.display='none'\" sizes=\"(max-width: 768px) 100vw, 100vw\" srcset=\"data:image\/svg+xml;utf8,<svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/>&#8221; data-srcset=&#8221;https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_gallery.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_gallery-201&#215;300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_gallery-686&#215;1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_gallery-768&#215;1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_gallery-630&#215;940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_gallery-420&#215;627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_gallery-315&#215;470.png 315w&#8221;>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Long-Acting Injectable Formulation Technologies: Challenges and Opportunities for the Delivery of Fragile Molecules\n\t<\/h3>\n\t<ul>\n<li>Successful technologies for long acting injectable formulations and their limitations<\/li>\n<li>Competitive advantages of injectable in situ forming implant formulation technologies<\/li>\n<li>Specific formulation challenges for fragile molecules (peptides and proteins) &#8211; Recent progress from long acting in situ forming implant formulation development<\/li>\n<\/ul>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Jo\u00ebl Richard, PhD, HDR Chief Development Officer at MedinCell Dr Jo\u00ebl Richard is currently Chief Development Officer at MedinCell (Montpellier, France). He is leading all the drug development activities of the company, based on the proprietary technology BEPO\u00ae for Long-Acting Injectables. (LAIs). These activities comprise formulation and process development, device development, analytical development, process transfer&#8230;<\/p>\n","protected":false},"author":1,"featured_media":35577,"parent":35042,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-35576","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Jo\u00ebl Richard &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Dr Jo\u00ebl Richard is currently Chief Development Officer at MedinCell (Montpellier, France). He is leading all the drug development activities of the company, based on the proprietary technology BEPO\u00ae for Long-Acting Injectables.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jo\u00ebl Richard &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Dr Jo\u00ebl Richard is currently Chief Development Officer at MedinCell (Montpellier, France). He is leading all the drug development activities of the company, based on the proprietary technology BEPO\u00ae for Long-Acting Injectables.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-19T10:54:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_profile.png\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/\",\"name\":\"Jo\u00ebl Richard &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_profile.png\",\"datePublished\":\"2021-01-11T15:18:57+00:00\",\"dateModified\":\"2021-03-19T10:54:29+00:00\",\"description\":\"Dr Jo\u00ebl Richard is currently Chief Development Officer at MedinCell (Montpellier, France). He is leading all the drug development activities of the company, based on the proprietary technology BEPO\u00ae for Long-Acting Injectables.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_profile.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_profile.png\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pre-filled Syringes &#038; Injectables 2021 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Jo\u00ebl Richard\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Jo\u00ebl Richard &#8226; BioTech Pharma Summit","description":"Dr Jo\u00ebl Richard is currently Chief Development Officer at MedinCell (Montpellier, France). He is leading all the drug development activities of the company, based on the proprietary technology BEPO\u00ae for Long-Acting Injectables.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/","og_locale":"en_US","og_type":"article","og_title":"Jo\u00ebl Richard &#8226; BioTech Pharma Summit","og_description":"Dr Jo\u00ebl Richard is currently Chief Development Officer at MedinCell (Montpellier, France). He is leading all the drug development activities of the company, based on the proprietary technology BEPO\u00ae for Long-Acting Injectables.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-03-19T10:54:29+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_profile.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/","name":"Jo\u00ebl Richard &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_profile.png","datePublished":"2021-01-11T15:18:57+00:00","dateModified":"2021-03-19T10:54:29+00:00","description":"Dr Jo\u00ebl Richard is currently Chief Development Officer at MedinCell (Montpellier, France). He is leading all the drug development activities of the company, based on the proprietary technology BEPO\u00ae for Long-Acting Injectables.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_profile.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/01\/Joel_RICHARD_medincell_BioTech_Pharma_Summit_2021_profile.png","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/joel-richard\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Pre-filled Syringes &#038; Injectables 2021 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/"},{"@type":"ListItem","position":3,"name":"Jo\u00ebl Richard"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/35576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=35576"}],"version-history":[{"count":4,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/35576\/revisions"}],"predecessor-version":[{"id":36241,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/35576\/revisions\/36241"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/35042"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/35577"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=35576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}